Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
View Patent ↗Methods are provided for coating crystalline microparticles with an active agent by altering the surface properties of the microparticles in order to facilitate favorable association on the microparticle by the active agent. Type of surface properties that are altered by the disclosed methods include by electrostatic properties, hydrophobic properties and hydrogen bonding properties.
1. A microparticle comprising a fumaryl diketopiperazine (FDKP) core microparticle and an insulin coating, wherein the insulin coating is about 9% to about 12% of the total weight of the microparticle.
2. The microparticle of claim 1 , wherein the insulin coating is a continuous or non-continuous monolayer.
3. The microparticle of claim 1 , wherein at least about 9% insulin, based upon the total weight of the microparticle, is bound to the core microparticle.
4. The microparticle of claim 3 , wherein at least 75% of the insulin coating is bound to the core microparticle.
5. The microparticle of claim 4 , wherein the insulin coating is bound so that at least 75% of the insulin coating will remain on the core microparticle surface when the microparticle is dispersed in water.
6. The microparticle of claim 3 , wherein at least about 9% insulin, based upon the total weight of the microparticle, is electrostatically bound to the core microparticle.
7. The microparticle of claim 1 , wherein the insulin coating is about 11.4% of the total weight of microparticle.
8. The microparticle of claim 1 , wherein the core microparticle further comprises polysorbate 80.
9. The microparticle of claim 7 , wherein the core microparticle further comprises polysorbate 80.
10. The microparticle of claim 9 , wherein the polysorbate 80 is present in an amount of at least 0.007 mg/mg of microparticle.